Steve Baín

1.8k citations

51 papers · 1.1k indexed · h-index 20

Impact in

Endocrinology, Diabetes and Metabolism top 2%
- Diabetes Management and Research
- Diabetes Treatment and Management
Nephrology top 5%
- Chronic Kidney Disease and Diabetes

Papers in ⓘ

Endocrinology, Diabetes and Metabolism 24
- Diabetes Treatment and Management 15
- Diabetes Management and Research 13
- Hyperglycemia and glycemic control in critically ill and hospitalized patients 4
Surgery 19
- Pancreatic function and diabetes 12

Co-authors: Jeffrey W. Stephens (9 shared papers)Jiten Vora (2 shared papers)Anthony Barnett (5 shared papers)Sarah L. Prior (6 shared papers)Torsten Christensen (1 shared paper)John A. Todd (3 shared papers)L E Pritchard (2 shared papers)Sankalpa Neupane (1 shared paper)
Journals: Diabetic Medicine (5 papers)Diabetes Therapy (5 papers)Diabetologia (4 papers)BMC Nephrology (2 papers)Primary care diabetes (2 papers)
Partner nations: United Kingdom United States Denmark

In The Last Decade

Steve Baín

49 papers receiving 1.1k citations

Peers

Countries citing papers authored by Steve Baín

Since Specialization

Citations

This map shows the geographic impact of Steve Baín's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steve Baín with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steve Baín more than expected).

Fields of papers citing papers by Steve Baín

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steve Baín. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steve Baín. The network helps show where Steve Baín may publish in the future.

Co-authors

The 25 scholars most cited alongside Steve Baín, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Steve Baín Line = papers co-authored together Steve Baín links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Accuracy and Longevity of an Implantable Continuous Glucose Sensor in the PRECISE Study: A 180-Day, Prospective, Multicenter, Pivotal Trial Diabetes Care ·Jort Kropff, Pratik Choudhary, Sankalpa Neupane, Katharine Barnard‐Kelly, Steve Baín, Christoph Kapitza, Thomas Först, Manuela Link, A. DeHennis, J. Hans DeVries	2016	131
2	Insulin gene region–encoded susceptibility to type 1 diabetes is not restricted to HLA–DR4–positive individuals Nature Genetics ·Steve Baín, Jan‐Bas Prins, Catherine M. Hearne, Nanda R. Rodrigues, B R Rowe, L E Pritchard, Rachael J. Ritchie, James Hall, Dag E. Undlien, K. S. Rønningen, David B. Dunger, Anthony Barnett, John A. Todd	1992	103
3	Insulin Degludec Versus Insulin Glargine in Type 1 and Type 2 Diabetes Mellitus: A Meta-Analysis of Endpoints in Phase 3a Trials Diabetes Therapy ·Jiten Vora, Torsten Christensen, Azhar Rana, Steve Baín	2014	76
4	LINKAGE MAPPING OF TYPE-1 DIABETES The American Journal of Human Genetics ·June Davies, James Copeman, Heather J. Cordell, Francesco Cucca, Gough Scl., Juliet V. Goy, Suzanne Jenkins, Yasushi Kawaguchi, Marilyn E. Merriman, Tony R. Merriman, L E Pritchard, A. F. Wilson, A H Barnett, Steve Baín, John A. Todd	1995	72
5	SGLT2 Inhibitors in Type 2 Diabetes Management: Key Evidence and Implications for Clinical Practice Diabetes Therapy ·John Wilding, Kevin Fernando, Nicola Milne, Marc Evans, Amar Ali, Steve Baín, Debbie Hicks, June James, Philip Newland‐Jones, Dipesh Patel, Adie Viljoen	2018	68
6	Correction of the mineralization defect in hyp mice treated with protease inhibitors CA074 and pepstatin Bone ·Peter Rowe, Naoko Matsumoto, Oak D. Jo, Remi Shih, Jeannine Oconnor, Martine P. Roudier, Steve Baín, Shiguang Liu, Jody S. Harrison, Norimoto Yanagawa	2006	47
7	Management of hypertension and renin-angiotensin-aldosterone system blockade in adults with diabetic kidney disease: Association of British Clinical Diabetologists and the Renal Association UK guideline update 2021 BMC Nephrology ·Debasish Banerjee, Peter Winocour, Tahseen A Chowdhury, P. De, Mona Wahba, Rosa Montero, Damian Fogarty, Andrew Frankel, Janaka Karalliedde, Patrick B. Mark, Dipesh Patel, Ana Pokrajac, Adnan Sharif, Sagen Zac‐Varghese, Steve Baín, Indranil Dasgupta	2022	46
8	Nitric oxide synthase gene polymorphisms and diabetic nephropathy Diabetologia ·J. D. Rippin, Ashok Patel, Nikolai D. Belyaev, GV Gill, A H Barnett, Steve Baín	2003	44
9	High-resolution linkage mapping for susceptibility genes in human polygenic disease: insulin-dependent diabetes mellitus and chromosome 11q. PubMed ·Randall N. Hyer, Cécile Julier, Jonathan D. Buckley, Massimo Trucco, Jerome I. Rotter, Richard S. Spielman, Anthony Barnett, Steve Baín, Christian Boîtard, I Deschamps	1991	44
10	A missense mutation in the hepatocyte nuclear factor 4 alpha gene in a UK pedigree with maturity-onset diabetes of the young Diabetologia ·M. Bulman, M. J. Dronsfield, Timothy M. Frayling, M. Appleton, Steve Baín, Sian Ellard, Andrew T. Hattersley	1997	40
11	SGLT2 Inhibitors: Cardiovascular Benefits Beyond HbA1c—Translating Evidence into Practice Diabetes Therapy ·Amar Ali, Steve Baín, Debbie Hicks, Phillip Newland Jones, Dipesh Patel, Marc Evans, Kevin Fernando, June James, Nicola Milne, Adie Viljoen, John Wilding	2019	37
12	Association between the rs4880 superoxide dismutase 2 (C>T) gene variant and coronary heart disease in diabetes mellitus Diabetes Research and Clinical Practice ·D. A. Jones, Sarah L. Prior, Tricia S. Tang, Steve Baín, Steven J. Hurel, Steve E. Humphries, Jeffrey W. Stephens	2010	35
13	The Effect of Glucagon-Like Peptide-1 Receptor Agonists on Renal Outcomes in Type 2 Diabetes Diabetes Therapy ·Win Yin, Steve Baín, Thinzar Min	2020	35
14	The TGF‐β1 gene codon 10 polymorphism contributes to the genetic predisposition to nephropathy in Type 1 diabetes Diabetic Medicine ·Ashok Patel, William R. Scott, Penny Lympany, J. D. Rippin, Geoff Gill, (unknown), Anthony Barnett, Steve Baín	2004	31
15	Adiponectin, total antioxidant status, and urine albumin excretion in the low-risk “Golden Years” type 1 diabetes mellitus cohort Metabolism ·Sarah L. Prior, Ting Tang, Geoff Gill, Steve Baín, Jeffrey W. Stephens	2010	27
16	Impact of pre‐exercise rapid‐acting insulin reductions on ketogenesis following running in Type 1 diabetes Diabetic Medicine ·Richard M. Bracken, Daniel J. West, Jeffrey W. Stephens, Liam P. Kilduff, Stephen D. Luzio, Steve Baín	2010	26
17	Lack of association of angiotensin II type 1 receptor gene polymorphism with diabetic nephropathy in insulin-dependent diabetes mellitus Diabetic Medicine ·T A Chowdhury, Philip Dyer, Sudhesh Kumar, Stephen Gough, S. P. Gibson, B R Rowe, Paul Smith, M. J. Dronsfield, Sally M. Marshall, Paul Mackin, John Dean, Peter J. Morris, S. Davies, David B. Dunger, A. J. M. Boulton, Anthony Barnett, Steve Baín	1997	24
18	The management of diabetes in terminal illness related to cancer QJM ·E. J. King, Hasan Haboubi, D. Gareth Evans, Ian Baker, Steve Baín, Jeffrey W. Stephens	2011	24
19	A Randomized Controlled, Treat-to-Target Study Evaluating the Efficacy and Safety of Insulin Glargine 300 U/mL (Gla-300) Administered Using Either Device-Supported or Routine Titration in People With Type 2 Diabetes Journal of Diabetes Science and Technology ·Melanie J. Davies, Steve Baín, G. Charpentier, Frank Flacke, Harmonie Goyeau, Michael Woloschak, Christoph Hasslacher, Giacomo Vespasiani, Steven V. Edelman	2019	23
20	Management of type 2 diabetes: t he current situation and key opportunities to improve care in the UK Diabetes Obesity and Metabolism ·Steve Baín, Michael Feher, David Russell‐Jones, Kamlesh Khunti	2016	21

About Steve Baín

Steve Baín is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery, Molecular Biology, Genetics and Nephrology, having authored 51 papers that have together received 1.1k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (15 papers), Diabetes Management and Research (13 papers), Pancreatic function and diabetes (12 papers), Diabetes and associated disorders (6 papers), Chronic Kidney Disease and Diabetes (4 papers), Diet and metabolism studies (4 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (4 papers) and Metabolism, Diabetes, and Cancer (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (548 citations), Nephrology (100 citations), Genetics (374 citations), Surgery (341 citations) and Cardiology and Cardiovascular Medicine (112 citations). Steve Baín has collaborated with scholars based in United Kingdom, United States and Denmark. Frequent co-authors include Jeffrey W. Stephens, Jiten Vora, Anthony Barnett, Sarah L. Prior, Torsten Christensen, John A. Todd, L E Pritchard, Sankalpa Neupane, A H Barnett and Thomas Först. Their work appears in journals such as Diabetic Medicine, Diabetes Therapy, Diabetologia, BMC Nephrology and Primary care diabetes.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact